Prentice Wealth Management LLC Amgen Inc Transaction History

Prentice Wealth Management LLC

$329 Million
Q3 2024

A detailed history of Prentice Wealth Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Prentice Wealth Management LLC holds 1,610 shares of AMGN stock, worth $417,473. This represents 0.16% of its overall portfolio holdings.

Number of Shares

1,610

Previous 877 83.58%

Holding current value

$417,473

Previous $274,000 89.05%

% of portfolio

0.16%

Previous 0.09%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	BUY	$309.38 - $337.38 $226,775 - $247,299	733 Added 83.58%	1,610 $518,000
Q2 2024 Jul 11, 2024	BUY	$262.75 - $319.31 $17,078 - $20,755	65 Added 8.0%	877 $274,000
Q3 2023 Oct 13, 2023	BUY	$218.65 - $271.46 $177,543 - $220,425	812 New	812 $218,000
Q1 2023 Apr 14, 2023	SELL	$225.79 - $275.2 $15,127 - $18,438	-67 Reduced 7.17%	867 $209,000
Q4 2022 Jan 18, 2023	SELL	$229.03 - $291.01 $19,009 - $24,153	-83 Reduced 8.16%	934 $0
Q3 2022 Oct 19, 2022	BUY	$224.46 - $253.15 $228,275 - $257,453	1,017 New	1,017 $229,000
Q2 2022 Jul 28, 2022	SELL	$230.71 - $256.74 $316,303 - $351,990	-1,371 Closed	0 $0
Q1 2022 Oct 31, 2022	BUY	$219.27 - $242.57 $107,880 - $119,344	492 Added 48.38%	1,509 $365,000
Q4 2021 Oct 31, 2022	BUY	$198.88 - $227.6 $67,619 - $77,384	340 Added 33.43%	1,357 $304,000
Q3 2021 Nov 10, 2021	SELL	$212.27 - $248.7 $4,457 - $5,222	-21 Reduced 1.51%	1,371 $292,000
Q2 2021 Aug 11, 2021	BUY	$233.58 - $259.14 $76,380 - $84,738	327 Added 30.7%	1,392 $339,000
Q1 2021 Jun 17, 2021	SELL	$221.91 - $258.6 $58.6 Million - $68.2 Million	-263,918 Reduced 99.6%	1,065 $265,000
Q1 2021 Jun 08, 2021	BUY	$221.91 - $258.6 $58.8 Million - $68.5 Million	264,983 New	264,983 $265,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $139B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prentice Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prentice Wealth Management LLC with notifications on news.

Account

Prentice Wealth Management LLC Amgen Inc Transaction History